Both in Pharmaceuticals
Acrivon Therapeutics vs MAIA Biotechnology
Over the past year ACRV returned −19.1% and MAIA returned +3.6%; their daily moves had a correlation of 0.15.
ACRV −19.1% MAIA +3.6%Growth of $1, one year, split-adjusted
| Metric | ACRV | MAIA |
|---|---|---|
| Price | $1.74 | $1.14 |
| Market cap | $74.6M | $70.4M |
| Today | +4.19% | +5.56% |
| 1 month | −6.5% | −4.2% |
| 6 months | −16.7% | −15.6% |
| Year to date | −27.8% | −25.5% |
| 1 year | −25.3% | −1.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $90.0M | $27.6M |
| Dividend yield | — | — |
| Volatility (60d) | 71.1% | 48.7% |
| Short % of float | 7.2% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).